Safety and Feasibility of Low-Dose Apatinib Combined with S-1 as the Second-Line Therapy or Beyond in Chinese Patients with Pulmonary and Hepatic Metastasis of Nasopharyngeal Carcinoma

Safety and Feasibility of Low-Dose Apatinib Combined with S-1 as the Second-Line Therapy or Beyond in Chinese Patients with Pulmonary and Hepatic Metastasis of Nasopharyngeal Carcinoma

Liya Zhou,* Jie Lin,* Gang Wu, Jiawei Chen, Xiaopeng Huang, Shuai Zhang Department of Radiation Oncology, Hainan General Hospital, Hainan Affiliated Hospital of Hainan Medical University, Haikou, Hainan Province 570311, People’s Republic of China*These authors contributed equally to this w...

Full description

Bibliographic Details
Main Authors: Zhou L, Lin J, Wu G, Chen J, Huang X, Zhang S
Format: Article
Language:English
Published: Dove Medical Press 2020-03-01
Series:Drug Design, Development and Therapy
Subjects:
nasopharyngeal carcinoma (npc)
metastasis
apatinib
s-1
prognosis
Online Access:https://www.dovepress.com/safety-and-feasibility-of-low-dose-apatinib-combined-with-s-1-as-the-s-peer-reviewed-article-DDDT

Internet

https://www.dovepress.com/safety-and-feasibility-of-low-dose-apatinib-combined-with-s-1-as-the-s-peer-reviewed-article-DDDT

Similar Items